testing guidelines

A new study examined post-treatment evaluation methods of head and neck squamous cell carcinoma in the context of advanced imaging and value-based care.
A continuing medical education session at the Society of Gynecologic Oncology’s 2018 Annual Meeting on Women’s Cancer offered insight for optimal selection and administration of PARP inhibitors, as well as homologous recombination deficiency testing in ovarian cancer.
The International Association for the Study of Lung Cancer has published its first version of the Atlas of EGFR Testing in Lung Cancer.
The American Society of Clinical Oncology and Friends of Cancer Research recently released a joint recommendation to promote inclusiveness for cancer clinical trial enrollment criteria.

Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology Association (June 22-25, 2017; Madrid, Spain).


Related Content

The American College of Obstetricians and Gynecologists has recently updated its clinical guidelines for the management of hereditary breast and ovarian cancer syndrome.
Sequencing cell-free DNA may be able to provide baseline information on actionable mutations and improve the quality of care in colorectal cancer.
Less than 20% of patients with a history of ovarian cancer meeting NCCN guidelines have undergone genetic testing or have discussed testing with their health care providers.
A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma.
The number of eligibility criteria and screening procedures in lung cancer clinical trials continue to rise.